Zacks Investment Research on MSN
Ginkgo Bioworks Holdings, Inc. (DNA) Dips More Than Broader Market: What You Should Know
Ginkgo Bioworks Holdings, Inc. (DNA) ended the recent trading session at $15.12, demonstrating a -4.49% change from the preceding day's closing price. The stock trailed the S&P 500, which registered a ...
TOKYO and BOSTON, May 14, 2024 /PRNewswire/ -- Sojitz, a large Japanese general trading company with extensive networks within the Japanese bioeconomy, and Ginkgo Bioworks (DNA), which is building the ...
Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence. An announcement from Ginkgo Bioworks ...
BOSTON, Aug. 20, 2025 /PRNewswire/ -- Ginkgo Bioworks (NYSE: DNA), which is building the leading platform for cell programming and biosecurity, today announced that its Datapoints offering has entered ...
A Federal Court authorized this Notice. This is not a solicitation from a lawyer. TO: ALL PERSONS OR ENTITIES WHO OR WHICH HELD SHARES OF GINKGO BIOWORKS HOLDINGS, INC. ("GINKGO" OR "THE COMPANY") ...
Ginkgo Bioworks reports that its Datapoints offering has entered into a new strategic partnership with Inductive Bio and Tangible Scientific to make AI-driven lab-in-the-loop drug discovery broadly ...
Who is Ginkgo Bioworks, Inc. Ginkgo Bioworks, Inc. does not have any significant net worth to report based on the numbers we have. This is based on reported shares in SYNLOGIC, INC..
To continue reading this content, please enable JavaScript in your browser settings and refresh this page. Preview this article 1 min After scrapping its plans for an ...
Every year, the federal government’s Small Business Innovation Research program pumps billions into startups across the country to help them develop new technologies and bring them closer to ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback